Evidence-Informed Milestones for Developmental Surveillance Tools
Overview
Authors
Affiliations
The Centers for Disease Control and Prevention's (CDC) Learn the Signs. Act Early. program, funded the American Academy of Pediatrics (AAP) to convene an expert working group to revise its developmental surveillance checklists. The goals of the group were to identify evidence-informed milestones to include in CDC checklists, clarify when most children can be expected to reach a milestone (to discourage a wait-and-see approach), and support clinical judgment regarding screening between recommended ages. Subject matter experts identified by the AAP established 11 criteria for CDC milestone checklists, including using milestones most children (≥75%) would be expected to achieve by specific health supervision visit ages and those that are easily observed in natural settings. A database of normative data for individual milestones, common screening and evaluation tools, and published clinical opinion was created to inform revisions. Application of the criteria established by the AAP working group and adding milestones for the 15- and 30-month health supervision visits resulted in a 26.4% reduction and 40.9% replacement of previous CDC milestones. One third of the retained milestones were transferred to different ages; 67.7% of those transferred were moved to older ages. Approximately 80% of the final milestones had normative data from ≥1 sources. Social-emotional and cognitive milestones had the least normative data. These criteria and revised checklists can be used to support developmental surveillance, clinical judgment regarding additional developmental screening, and research in developmental surveillance processes. Gaps in developmental data were identified particularly for social-emotional and cognitive milestones.
Wu S, Pan H, Sheldrick R, Shao J, Liu X, Zheng S World J Pediatr. 2025; 21(2):183-191.
PMID: 39988643 DOI: 10.1007/s12519-025-00878-7.
Long-term ocular sequelae in preterm Thai infants: A comprehensive retrospective study.
Srimanan W, Kitsirilarp W Medicine (Baltimore). 2025; 104(6):e41485.
PMID: 39928793 PMC: 11812997. DOI: 10.1097/MD.0000000000041485.
Mangum L, Copeland V, Orebiyi I, Taylor S, Jones T, Nathan J J Racial Ethn Health Disparities. 2025; .
PMID: 39875762 DOI: 10.1007/s40615-025-02283-2.
Cibralic S, Hawker P, Khan F, Lucien A, Mendoza Diaz A, Woolfenden S Front Child Adolesc Psychiatry. 2025; 2():1074004.
PMID: 39816889 PMC: 11732054. DOI: 10.3389/frcha.2023.1074004.
Variants in associated with cancer and rare developmental and epileptic encephalopathy.
Solano E, Foksinska A, Crowder C Front Pediatr. 2024; 12:1448793.
PMID: 39736890 PMC: 11683136. DOI: 10.3389/fped.2024.1448793.